Sunday - August 24, 2025
Gibson Dunn Advises XOMA Royalty on Acquisition of Mural Oncology
August 21, 2025
LOS ANGELES, California, Aug. 21 [Category: BizLaw/Legal] -- Gibson, Dunn and Crutcher, a law firm, issued the following news:

* * *

Gibson Dunn Advises XOMA Royalty on Acquisition of Mural Oncology

*

Gibson Dunn is advising XOMA Royalty Corporation on its acquisition of Mural Oncology plc.

XOMA Royalty is a publicly traded biotech royalty aggregator. Mural Oncology is a biopharmaceutical company focused on discovering and develop . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products